ProQR Therapeutics N.V. (PRQR) stock prices updated...
 

ProQR Therapeutics N.V. stock price

ProQR Therapeutics N.V. latest news:


  • 11/20/2017 05:12:39

    BRIEF-Proqr reports loss of EUR 0.42 per share​

    * Proqr Therapeutics Nv - ‍net result for three month period ended September 30, 2017 was a EUR 10.5 million loss or EUR 0.42 per share​ Source text for Eikon: Further company coverage:

  • 11/14/2017 05:48:28

    BRIEF-ProQR Therapeutics prices public offering

    ProQR Therapeutics Nv(PRQR). * ProQR prices approximately $20 million underwritten public offering and concurrent registered direct offering of ordinary shares. * Pricing of offering of its ordinary shares at a price to public of $3.25 per share​ Source text for Eikon: Further company coverage:

  • 11/13/2017 14:30:13

    BRIEF-Proqr announces proposed public offering of ordinary shares

    Proqr Therapeutics Nv(PRQR). * Proqr announces proposed public offering of ordinary shares. * Proqr - To use proceeds from both offerings to fund clinical trials, ongoing research & development activities​ Source text for Eikon: Further company coverage:

  • 10/11/2017 15:25:11

    BRIEF-JDG B.V. reports 10.5 pct passive stake in ProQR Therapeutics NV as on Sept 14

    * JDG B.V. Reports 10.5 percent passive stake in ProQR Therapeutics NV as on September 14 - SEC Filing‍​ Source text: (http://bit.ly/2yhtqSA) Further company coverage:

  • More trends:

    ProShares Ultra search BiotechnologyBIB | Proshares UltraPro search BiotechnologyUBIO | ProShares UltraPro QQQTQQQ | ProShares UltraPro Short search BiotechnologyZBIO | ProShares UltraPro Short QQQSQQQ | ProShares UltraShort search BiotechnologyBIS | Prospect Capital CorporationPSEC | Proteon Therapeutics, Inc.PRTO | Prothena Corporation plcPRTA | Providence and Worcester Railroad CompanyPWX |